Masato Yoshihara
Overview
Explore the profile of Masato Yoshihara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujita K, Hayashi M, Yoshihara M, Nomura S, Kitami K, Miyamoto E, et al.
Med Mol Morphol
. 2025 Feb;
PMID: 39964447
Ovarian cancer (OvCa) is a leading cause of gynecological cancer-related mortality, primarily due to peritoneal dissemination, which facilitates metastasis in the abdominal cavity. This study explored the potential of vitamin...
2.
Hattori S, Yoshikawa N, Liu W, Matsukawa T, Kubokawa M, Yoshida K, et al.
Cancer Immunol Immunother
. 2025 Jan;
74(2):70.
PMID: 39751650
Objectives: We focused on how the immunophenotypes based on the distribution of CD8-positive tumor-infiltrating lymphocytes (TILs) relate to the endometrial cancer (EC) molecular subtypes and patients' prognosis. Patients And Methods:...
3.
Tano S, Kotani T, Ushida T, Matsuo S, Yoshihara M, Imai K, et al.
Hypertens Res
. 2024 Dec;
48(3):884-893.
PMID: 39663391
The growing recognition of the importance of interpregnancy weight management in reducing hypertensive disorders of pregnancy (HDP) underscores the importance of effective preventive strategies. However, developing effective systems remains a...
4.
Iyoshi S, Kimura M, Yoshihara M, Kunishima A, Miyamoto E, Fujimoto H, et al.
BMC Cancer
. 2024 Nov;
24(1):1479.
PMID: 39614202
Background: The accumulation of ascites is a major symptom of ovarian cancer. The volume of ascites is a pathophysiological indicator of the peritoneal environment, such as inflammation and fibrosis; however,...
5.
Mogi K, Yoshihara M, Emoto R, Miyamoto E, Fujimoto H, Uno K, et al.
PLoS One
. 2024 Nov;
19(11):e0311421.
PMID: 39585874
Objective: Assessing the histology-specific prognosis of epithelial ovarian cancer (OvCa) is clinically challenging, especially in a patient population with a favorable prognosis. This study investigated the histology-specific long-term oncologic outcomes...
6.
Mogi K, Tomita H, Yoshihara M, Kajiyama H, Hara A
Gene
. 2024 Oct;
934:149014.
PMID: 39461574
Transgenic mice, including those created using Bacterial Artificial Chromosomes (BACs), are artificial manipulations that have become critical tools for studying gene function. While conventional transgenic techniques face challenges in achieving...
7.
Fujimoto H, Yoshihara M, Ricciardelli C, Tano S, Iyoshi S, Miyamoto E, et al.
Sci Rep
. 2024 Oct;
14(1):23537.
PMID: 39384823
Ovarian cancer (OvCa) is one of the most lethal gynecological malignancies, and most patients are diagnosed at advanced stage with peritoneal dissemination. Although age at diagnosis is considered an independent...
8.
Shibata M, Yoshida K, Yokoi A, Suzuki H, Yamamoto Y, Kitagawa M, et al.
Gynecol Oncol
. 2024 Aug;
190:189-199.
PMID: 39216132
Objective: A complete hydatidiform mole (CHM) is a common disease and is known to develop post-molar gestational trophoblast neoplasia (GTN). However, the molecular mechanisms underlying the progression of CHM to...
9.
Taniguchi T, Mogi K, Tomita H, Okada H, Mori K, Imaizumi Y, et al.
Pathol Res Pract
. 2024 Aug;
262:155538.
PMID: 39191196
The mesothelium is a non-adhesive protective surface that lines the serosal cavities and organs within the body. The glycocalyx is a complex structure that coats the outer layer of the...
10.
Tamauchi S, Nakagawa A, Yoshida K, Yoshihara M, Yokoi A, Yoshikawa N, et al.
J Obstet Gynaecol Res
. 2024 Aug;
50(9):1614-1621.
PMID: 39092804
Aims: To evaluate the safety and effectiveness of high-dose oral medroxyprogesterone acetate (MPA) therapy as a fertility-sparing treatment for patients diagnosed with atypical endometrial hyperplasia (AEH) and endometrioid carcinoma G1...